About

BioMedInnovations LLC (BMI) has invented and extensively tested a life-changing technology for organ perfusion.  A technology platform so intricate and esteemed wouldn’t have came about without educated and driven staff and board members. Each member of BioMed Innovations is highly important to the success of this radical science.

EXECUTIVE MANAGEMENT

Sherif Gabriel, CEO

Carrie DiMarzio, COO

Tony Arndt, VP ENG

  • Experience Includes:
  • UNC
  • NIVALIS Therapeutics
  • H.C. WAINWRIGHT
  • Experience Includes:
  • Industrial Hard Carbon
  • Experience Includes:
  • IHC
  • Technical Advantage Inc.

MEDICAL ADVISORY BOARD

David Gerber, MD

Gerry Lake-Bakaar, MD, Ph.D.

Gluseppe Orlando, MD

Fred Gage, Ph.D.

  • Experience Includes:
  • UNC
  • George F. Sheldon
  • Distinguished Professor and Vice Chair – Clinical Affairs
  • Experience Includes:
  • Transplant Hepatologist
  • Transplant Ctr. Porter
  • Adventist Hospital
  • Experience Includes:
  • Renal Surgeon, Wake Forest Baptist Hospital Transplant
  • Experience Includes:
  • Sentient
  • Perfusion Lab

Chief Executive Officer

Sherif Gabriel Ph.D. BiomedInnovations (LLC)
919-260-9762

info2019@BioMedInnovationsLLC.com

Chief Operating Officer

Carrie DiMarzio BiomedInnovations (LLC)
704-999-5897

info2019@BioMedInnovationsLLC.com

CaVESWave®

the future of precision perfusion

CaVESWave® is an investigative device in the preclinical stage of development. It has not yet been tested extensively on humans or approved for commercial sale by the FDA or by any other regulatory body. ©BMI Proprietary and Confidential